88
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9491 |
Pyraclostrobin
|
Antibacterial; Antifungal | Microbiology/Virology |
Pyraclostrobin 是一种球果苷杀菌剂,可诱导 3T3-L1 细胞内甘油三酯的积累,还可抑制真菌和哺乳动物细胞的线粒体复合物 III 。 | |||
T13173 |
TMPA
|
Others; AMPK | Chromatin/Epigenetic; Others; PI3K/Akt/mTOR signaling |
TMPA 是一种核受体 Nur77 和 LKB1 相互作用的拮抗剂。 | |||
T61054 | Type II topoisomerase inhibitor 1 | ||
Type II topoisomerase inhibitor 1 可用于抗菌领域。Type II topoisomerase inhibitor 1 是大肠杆菌DNA 旋转酶的选择性抑制剂,IC50值为 1.7 nM,并能与 Asp73 残基形成氢键。Type II topoisomerase inhibitor 1 抑制拓扑异构酶 IV 的活性,IC50值为 0.98 μM。 | |||
T72289 | Type II TRK inhibitor 1 | Trk receptor | Tyrosine Kinase/Adaptors |
Type II TRK inhibitor 1 是有效抑制多种TRK融合蛋白及野生型的TRK抑制剂。对携有CD74-TRKAG667C及ETV6-TRKCG696C融合蛋白的Ba/F3细胞表现出抗增殖活性,其IC50值分别为6 nM与1.7 nM。 | |||
T12493 |
PK68
|
Others; RIP kinase | Apoptosis; NF-κB; Others |
PK68 是 II 型受体相互作用激酶 1 (RIPK1, IC50 = 90 nM) 的有效特异性抑制剂。 PK68可用于治疗炎症性疾病和癌症转移的研究。 | |||
T9924 |
Obinutuzumab
奥滨尤妥珠单抗,Obinutuzumab/afutuzumab |
Others | Others |
Obinutuzumab (Obinutuzumab/afutuzumab)/afutuzumab 是一种新型糖工程化 II 型 CD20单克隆抗体,用于研究非霍奇金淋巴瘤。 | |||
T9098 |
DMG-PEG 2000
DMG-PEG2000 |
Others | Others |
DMG-PEG 2000 (DMG-PEG2000) 可用于脂质纳米颗粒制备,用于口服质粒 DNA 的体内传递途径,提高纳米颗粒的黏液渗透性和传递效率。它也可用于 siRNA 转染的脂质体的制备,能够提高转染效率。 | |||
T20029 |
Buformin hydrochloride
NSC528218,NSC-528218,盐酸丁双胍,NSC 528218 |
AMPK | Chromatin/Epigenetic; PI3K/Akt/mTOR signaling |
Buformin hydrochloride (NSC-528218) 是一种有效的 AMPK 激活剂,是一种双胍类的口服抗糖尿病药物。Buformin 延缓胃肠道对葡萄糖的吸收,增加胰岛素敏感性和葡萄糖对细胞的吸收,并抑制肝脏对葡萄糖的合成。Buformin 也具有抗癌活性,可用于各种癌症研究。 | |||
T1615 |
Irbesartan
厄贝沙坦,SR-47436,BMS-186295 |
Apoptosis; RAAS | Apoptosis; Endocrinology/Hormones |
Irbesartan (SR-47436) 是一种 1 型血管紧张素 II 受体拮抗剂,IC50为1.3 nM。 | |||
T1800 |
GW788388
GW 788388 |
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
GW788388 是一种 ALK5抑制剂(IC50:18 nM)。它也抑制 TGF-β II 型受体和激活素 II 型受体的活性,但对 BMP II 型受体无影响。 | |||
TQ0061 |
CHZ868
|
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
CHZ868 是II型 JAK 抑制剂,具有潜在的抗肿瘤活性,可逆转 I 型 JAK 抑制剂的持续存在,可用于研究白血病。 | |||
T24612 |
Pentachloropseudilin
PClP |
||
Pentachloropseudilin is a selective inhibitor of Myosin-1. In target cells, It acts by suppressing transforming growth factor-β activity by accelerating cell-surface type II TGF-β receptor turnover. | |||
T15603 |
ITX5061
ITX-5061 |
HCV Protease; p38 MAPK | MAPK; Microbiology/Virology; Proteases/Proteasome |
ITX5061 是 p38 MAPK 的 II 型抑制剂和清道夫受体 B1(SRB1) 拮抗剂,可用于研究丙型肝炎病毒感染。 | |||
T2123 |
LY2109761
|
Autophagy; TGF-beta/Smad | Autophagy; Stem Cells |
LY2109761 是一种新型选择性 TGF-β 受体 I/II 型 (TβRI/II) 双重抑制剂,Ki 分别为 38 nM 和 300 nM。 | |||
T4268 |
CHMFL-BMX-078
|
BTK | Angiogenesis; Tyrosine Kinase/Adaptors |
CHMFL-BMX-078 是一种高效的、选择性的 II 型不可逆 BMX 激酶抑制剂,其 IC50=11 nM。 | |||
T0158 |
Mitoxantrone dihydrochloride
米托蒽醌二盐酸盐,盐酸米托蒽醌,Mitoxantrone 2HCl,Mitoxantrone hydrochloride,NSC-301739,mitozantrone dihydrochloride |
Topoisomerase; PKC | Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair |
Mitoxantrone dihydrochloride (NSC-301739) 是一种拓扑异构酶 II 的抑制剂;也可抑制蛋白激酶C (PKC),IC50值为8.5 μM。 | |||
T27643 |
Izonsteride
LY-320236,LY320236,UNII-A5E8C36F34 |
Reductase | Endocrinology/Hormones; Metabolism |
Izonsteride (LY320236) 是一种选择性强效 5α 还原酶抑制剂,对酶的 I 型和 II 型同工酶具有双重作用。Izonsteride 可用于治疗肿瘤和泌尿生殖系统疾病,可用于研究前列腺癌。 | |||
T16333 |
NKY80
Adenylyl cyclase type V Inhibitor |
Adenylyl cyclase | Neuroscience |
NKY80 调节心脏和肺组织中的腺苷酸环化酶催化活性。 NKY80 是腺苷酸环化酶 V 型亚型的非竞争性抑制剂(IC50 值:V、III 和 II 型分别为 8.3 µM、132 µM 和 1.7 mM)。 | |||
T10800 |
CHMFL-ABL-121
|
Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
CHMFL-ABL-121 是一种 II 型 ABL 激酶高效抑制剂,抑制纯化的非活性 ABL wt 和 T315I 激酶蛋白的 IC50 值分别为 2 nM 和 0.2 nM。 | |||
T63544 |
RIPK3-IN-1
|
||
RIPK3-IN-1 是一种 II 型 RIPK3DFG-out 位点抑制剂 (IC50: 9.1 nM),能够抑制 RIPK1 (IC50: 5.5 μM) 和 RIPK2 (IC50>10 μM)。RIPK3-IN-1 是一种 c-Met 激酶抑制剂 (IC50: 1.1 μM)。 | |||
T2153 |
1-NM-PP1
PP1 Analog II,1 nM-PP1 |
Serine/threonin kinase; CDK; Src | Angiogenesis; Cell Cycle/Checkpoint; Metabolism; Tyrosine Kinase/Adaptors |
1-NM-PP1 (PP1 Analog II) 是一种有效的Src 家族激酶抑制剂,是一种细胞渗透性 PP1 类似物,对 v-Src-as1 与 c-Fyn-as1 的IC50值分别为 4.3 nM、3.2 nM。 | |||
T6866 |
AUZ 454
K03861 |
CDK | Cell Cycle/Checkpoint |
AUZ 454 (K03861) 是一种 II 型 CDK2 抑制剂,Kd 值是 8.2 nM。它对 CDK2(WT)、CDK2(C118L)、CDK2(A144C) 和 CDK2(C118L/A144C) 的 Kd 分别为 50 nM、18.6 nM、15.4 nM 和 9.7 nM。 | |||
T60085 |
MM3122
GTPL11533,MM-3122,Ac-GQFR-kbt |
SARS-CoV | Microbiology/Virology |
MM3122 (MM-3122) 是一种选择性的 II 型跨膜丝氨酸蛋白酶 (TMPRSS2) 抑制剂,IC50为 0.34 nM。MM3122 可以有效阻断 TMPRSS2,从而抑制 SARS-CoV-2 和 MERS-CoV 进入人类细胞。 | |||
T12730 |
RIPK1-IN-4
|
RIP kinase | Apoptosis; NF-κB |
RIPK1-IN-4 是有效的 II 型激酶受体相互作用蛋白1 (RIP1) 激酶抑制剂,并且与 DL1-out 无活性形式的 RIP1 结合。RIPK1-IN-4抑制 RIP1 和 ADP-Glo 激酶,IC50 分别是 16 nM 和 10 nM。 | |||
T78169 |
Enpp-1-IN-16
|
PDE | Metabolism |
Enpp-1-IN-16 是一种靶向 ENPP1 的抑制剂,具有潜在的抗癌症活性。Enpp-1-IN-16 可用于研究胰岛素抵抗与II型糖尿病和软骨钙化病和骨关节炎类由 ENPP1介导的各类疾病。 | |||
T38683 |
SCD1 inhibitor-3
SCD1-IN-3,SCD1 inhibitor-3,SCD1 inhibitor 17a |
Dehydrogenase | Metabolism |
SCD1 inhibitor-3 (ML-270) 是一种高效、口服的化合物,可以抑制SCD1,且安全性极高。 SCD1 inhibitor-3 显示出在代谢疾病(包括肥胖、二型糖尿病和血脂异常,以及痤疮和癌症等各种皮肤病)方面的巨大研究潜力。 | |||
T10799 |
CHMFL-ABL-039
|
Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
CHMFL-ABL-039 是一种具有高效选择性的 Ⅱ 型野生型 ABL 激酶和耐药 V299L 突变型 BCR-ABL 激酶的抑制剂,IC50 分别为 7.9 nM、27.9 nM。CHMFL-ABL-039 可用于慢性粒细胞白血病 (CML) 的研究。 | |||
TP2158 |
TRV-120027 TFA
TRV-120027 TFA (1234510-46-3 free base) |
RAAS; Arrestin | Endocrinology/Hormones; GPCR/G Protein |
TRV-120027 TFA 是一种血管紧张素 II 介导的血管收缩抑制剂,可增加心肌细胞的收缩力。它是一种偏向 β-arrestin-1 的 AT1R 激动剂,可与 ß-arrestins 结合,同时阻断 G 蛋白信号传导。 它通过阳离子通道亚家族 C3 (TRPC3) 偶联诱导急性儿茶酚胺分泌,并促进在质膜上形成由 AT1R-β-arrestin-1-TRPC3-PLCγ 组成的大分子复合物。 | |||
T30534 |
BMS-639432
|
||
BMS-639432 is a potent sodium-glucose cotransporter type II (SGLT2) inhibitor. | |||
T68967 |
AFG206
|
||
AFG206 is the novel first-generation type II" FLT3 inhibitor." | |||
T12114 |
MSC1094308
|
p97 | Ubiquitination |
MSC1094308 is a reversible and allosteric inhibitor of the type II AAA ATPase. | |||
T27848 |
LP10
LP-10,LP 10 |
||
LP10 is a reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1 and a Potent type II inhibitor of Trypanosoma cruzi CYP51. | |||
T28299 |
PAT-078
PAT078,PAT 078 |
||
PAT-078 is an inhibitor of type II autotaxin. | |||
T11391L |
Gepotidacin
GSK2140944 |
Others | Others |
Gepotidacin is a novel triazaacenaphthylene inhibitor of bacterial type II topoisomerase. | |||
T28301 |
PAT-494
PAT 494,PAT494 |
||
PAT-494 is an inhibitor of type II Autotaxin. | |||
T69702 |
AFG210
|
||
AFG210 is a novel first-generation “type II” FLT3 inhibitor. | |||
T27598 |
Imigliptin Dihydrochloride
Imigliptin |
||
Imigliptin Dihydrochloride, a selective dipeptidyl peptidase IV (DPP-4) inhibitor, is used potentially for the treatment of type II diabetes. | |||
T71354 | AMG-222 tosylate | ||
AMG-222 tosylate is a DPP-IV inhibitor in clinical development for type II diabetes. | |||
T24098 |
GP17
GP-17,GP 17 |
||
GP17 is a type II kinase inhibitor of the IRE1α endoribonuclease that acts by targeting the ATP-binding pocket of IRE1α. | |||
T24099 |
GP29
GP-29,GP 29 |
||
GP29 is a Type II kinase inhibitor of the IRE1α endoribonuclease that acts by targeting the ATP-binding pocket of IRE1α. | |||
T12396 |
PDGFRα kinase inhibitor 1
|
PDGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
PDGFRα kinase inhibitor 1 is a highly selective inhibitor of type II PDGFRα kinase (PDGFRα and PDGFRβ with IC50s of 132 nM and 6115 nM , respectively). | |||
T13406L |
Zabofloxacin hydrochloride
DW-224a |
Raf | MAPK |
Zabofloxacin hydrochloride is a potent and seletive bacterial type II and IV topoisomerases inhibitor, has excellent activity against gram-positive pathogens including Steptococcus aureus, Streptococcus pyogenes and S.pneumonia. | |||
T10647 |
c-Fms-IN-8
|
CSF-1R | Tyrosine Kinase/Adaptors |
c-Fms-IN-8 is a colony-stimulating factor-1 receptor (CSF-1R, c-FMS) Type II inhibitor (IC50: 9.1 nM). It is compound 4a in the reference. | |||
T13406 |
Zabofloxacin
DW-224a Free base |
Others | Others |
Zabofloxacin is a potent and seletive bacterial type II and IV topoisomerases inhibitor, and has excellent activity against gram-positive pathogens including Steptococcus aureus, Streptococcus pyogenes and S.pneumonia. | |||
T68558 | BML-288 | ||
BML-288 is a phosphodiesterase Type II (PDE2) inhibitor that demonstrates no inhibition of 5-lipoxygenase (5-LO) or cyclooxygenase (COX-1). | |||
T11559 |
HG-12-6
|
Others | Others |
HG-12-6 is a type II inhibitor of IRAK4. HG-12-6 shows preferential binding to unphosphorylated inactive IRAK4 (IC50: 165 nM). HG-12-6 can modulate IRAK4 activity in autoimmunity and inflammation. | |||
T61192 | CBR-6672 | ||
CBR-6672, a type II NADH dehydrogenase inhibitor, demonstrates potent antimycobacterial activity against mycobacterium tuberculosis (Mtb) with a minimum inhibitory concentration (MIC) of 0.14 μM [1]. | |||
T13125 | TD-0212 | Others | Others |
TD-0212 is an orally active dual pharmacology antagonist of angiotensin II type 1 receptor (AT1) and inhibitor of neprilysin (NEP)(pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP). | |||
T13125L | TD-0212 TFA | Others | Others |
TD-0212 TFA is an orally active dual pharmacology antagonist of angiotensin II type 1 receptor (AT1) and inhibitor of neprilysin (NEP)(pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP). | |||
T10801 |
CHMFL-ABL/KIT-155
CHMFL-ABL-KIT-155 |
c-Kit | Tyrosine Kinase/Adaptors |
CHMFL-ABL/KIT-155 is a highly potent and orally active type II ABL/c-KIT dual kinase inhibitor (IC50s: 46 nM/75 nM). It arrests cell cycle progression and induces apoptosis. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3417 |
Amentoflavone
Didemethyl-ginkgetin,穗花杉双黄酮,Amenthoflavone,3',8''-Biapigenin |
Apoptosis; P450; Phospholipase; Reactive Oxygen Species; Opioid Receptor; COX; Antibacterial; RSV; Antifungal | Apoptosis; Endocrinology/Hormones; GPCR/G Protein; Immunology/Inflammation; Metabolism; Microbiology/Virology; Neuroscience; NF-κB |
Amentoflavone (3',8''-Biapigenin) 是一种具有很多生物活性的双黄酮类天然产物,有抗炎、抗氧化和神经保护等作用。 | |||
T3S1612 |
kuwanon G
桑黄酮G,Moracenin B,桑黄酮 G,Kuwanone G |
Phosphatase; Antibacterial; Bombesin Receptor; AChR; AChE; Glucosidase | GPCR/G Protein; Metabolism; Microbiology/Virology; Neuroscience |
Kuwanon G (Moracenin B) 是一种从桑树中得到的黄酮类蛙皮素受体拮抗剂,具有杀菌作用。 | |||
T60692 |
Masoprocol
|
||
Masoprocol (meso-Nordihydroguaiaretic acid) 是口服有效的脂氧合酶 (lipoxygenase) 抑制剂。Masoprocol 具有出抗高血糖活性,可用于 II 型糖尿病的研究。 Masoprocol 可降低体内肝甘油三酯和葡萄糖浓度。 |